Ronald C. Renaud JR

Insider Reports History

Entity
Individual
Location
C/O Idenix Pharmaceuticals, Inc., 60 Hampshire Street, Cambridge, MA
Signature
/s/ Michael Gray, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ronald C. Renaud JR:

Insider Reports Filed by Ronald C. Renaud JR

Symbol Company Period Transactions Value $ Form Type Date Filed Role
UPB Upstream Bio, Inc. Oct 10, 2024 1 $0 4 Oct 15, 2024 Director
UPB Upstream Bio, Inc. Oct 10, 2024 0 $0 3 Oct 10, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Aug 1, 2024 5 $0 4 Aug 5, 2024 President & CEO, Director
CERE Cerevel Therapeutics Holdings, Inc. Jan 19, 2024 1 $0 4 Jan 23, 2024 President & CEO, Director
CERE Cerevel Therapeutics Holdings, Inc. Dec 19, 2023 2 $0 4 Dec 21, 2023 President & CEO, Director
CERE Cerevel Therapeutics Holdings, Inc. Aug 3, 2023 1 $2.01M 4 Aug 7, 2023 President & CEO, Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 12, 2023 3 $0 4 Jun 14, 2023 President & CEO, Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 12, 2023 0 $0 3 Jun 14, 2023 President & CEO, Director
ATRA Atara Biotherapeutics, Inc. Jun 23, 2022 2 $0 4 Jun 27, 2022 Director
IKNA Ikena Oncology, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
IKNA Ikena Oncology, Inc. Dec 21, 2021 1 $0 4 Dec 23, 2021 Director
TBIO Translate Bio, Inc. Sep 14, 2021 8 -$36.3M 4 Sep 14, 2021 Chief Executive Officer, Director
ATRA Atara Biotherapeutics, Inc. Jun 8, 2021 2 $0 4 Jun 9, 2021 Director
TBIO Translate Bio, Inc. Apr 7, 2021 2 $66.7K 4/A Sep 14, 2021 Chief Executive Officer, Director